Pericardiectomy for constrictive pericarditis: a risk factor analysis for early and late failure.


Journal

Heart and vessels
ISSN: 1615-2573
Titre abrégé: Heart Vessels
Pays: Japan
ID NLM: 8511258

Informations de publication

Date de publication:
Jan 2020
Historique:
received: 28 03 2019
accepted: 21 06 2019
pubmed: 27 6 2019
medline: 28 10 2020
entrez: 26 6 2019
Statut: ppublish

Résumé

Predictors of early and late failure of pericardiectomy for constrictive pericarditis (CP) have not been established. Early and late outcomes of a cumulative series of 81 (mean age 60 years; mean EuroSCORE II, 3.3%) consecutive patients from three European cardiac surgery centers were reviewed. Predictors of a combined endpoint comprising in-hospital death or major complications (including multiple transfusion) were identified with binary logistic regression. Non-parametric estimates of survival were obtained with the Kaplan-Meier method. Predictors of poor late outcomes were established using Cox proportional hazard regression. There were 4 (4.9%) in-hospital deaths. Preoperative central venous pressure > 15 mmHg (p = 0.005) and the use of cardiopulmonary bypass (p = 0.016) were independent predictors of complicated in-hospital course, which occurred in 29 (35.8%) patients. During follow-up (median, 5.4 years), preoperative renal impairment was a predictor of all-cause death (p = 0.0041), cardiac death (p = 0.0008), as well as hospital readmission due to congestive heart failure (p = 0.0037); while partial pericardiectomy predicted all-cause death (p = 0.028) and concomitant cardiac operation predicted cardiac death (p = 0.026), postoperative central venous pressure < 10 mmHg was associated with a low risk both of all-cause and cardiac death (p < 0.0001 for both). Ten-year adjusted survival free of all-cause death, cardiac death, and hospital readmission were 76.9%, 94.7%, and 90.6%, respectively. In high-risk patients with CP, performing pericardiectomy before severe constriction develops and avoiding cardiopulmonary bypass (when possible) could contribute to improving immediate outcomes post-surgery. Complete removal of cardiac constriction could enhance long-term outcomes.

Identifiants

pubmed: 31236676
doi: 10.1007/s00380-019-01464-4
pii: 10.1007/s00380-019-01464-4
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

92-103

Références

Circ J. 2017 Jan 25;81(2):206-212
pubmed: 27928144
Eur J Cardiothorac Surg. 2012 Apr;41(4):734-44; discussion 744-5
pubmed: 22378855
J Am Coll Cardiol. 2016 May 3;67(17):2061-76
pubmed: 27126534
Asian Cardiovasc Thorac Ann. 2018 Jun;26(5):347-352
pubmed: 29703105
J Cardiothorac Surg. 2015 Mar 19;10:34
pubmed: 25887705
Ann Thorac Surg. 2017 May;103(5):1429-1433
pubmed: 27825685
Ann Thorac Surg. 1983 Nov;36(5):605-6
pubmed: 6639198
Rev Esp Cardiol (Engl Ed). 2015 Dec;68(12):1092-100
pubmed: 25936614
Echocardiography. 2016 Oct;33(10):1589-1599
pubmed: 27539202
Ann Thorac Surg. 2015 Jul;100(1):107-13
pubmed: 25979240
Eur J Cardiothorac Surg. 2015 Dec;48(6):e110-6
pubmed: 26374871
J Card Surg. 1990 Dec;5(4):318-20
pubmed: 2133864
Thorac Cardiovasc Surg. 2018 Nov;66(8):645-650
pubmed: 28780766
Ann Thorac Surg. 2012 Aug;94(2):445-51
pubmed: 22621875
Ann Thorac Surg. 2018 Apr;105(4):1280
pubmed: 29571333
J Cardiothorac Surg. 2015 Jun 30;10:90
pubmed: 26123033
J Thorac Cardiovasc Surg. 2016 Aug;152(2):448-58
pubmed: 27210468
Eur J Cardiothorac Surg. 2013 Dec;44(6):1023-8; discussion 1028
pubmed: 23761416
Cardiovasc Diagn Ther. 2016 Oct;6(Suppl 1):S13-S19
pubmed: 27904840
Cardiol Clin. 2017 Nov;35(4):539-549
pubmed: 29025545
Heart. 2018 May;104(9):725-731
pubmed: 29175978
J Cardiothorac Surg. 2015 Nov 27;10:177
pubmed: 26613929
Ann Thorac Surg. 2017 Sep;104(3):742-750
pubmed: 28760468
J Card Surg. 2018 Jun;33(6):301-307
pubmed: 29761570

Auteurs

Giuseppe Gatti (G)

Cardio-Thoracic and Vascular Department, Trieste University Hospital, Trieste, Italy. gius.gatti@gmail.com.
Division of Cardiac Surgery, Ospedale Di Cattinara, Via P. Valdoni 7, 34148, Trieste, Italy. gius.gatti@gmail.com.

Antonio Fiore (A)

Department of Cardio-Thoracic Surgery, University Hospital Henri-Mondor, Créteil, Paris, France.

Julien Ternacle (J)

Department of Cardio-Thoracic Surgery, University Hospital Henri-Mondor, Créteil, Paris, France.

Aldostefano Porcari (A)

Cardio-Thoracic and Vascular Department, Trieste University Hospital, Trieste, Italy.

Ilaria Fiorica (I)

Cardio-Thoracic and Vascular Department, Trieste University Hospital, Trieste, Italy.

Angela Poletti (A)

Cardio-Thoracic and Vascular Department, Trieste University Hospital, Trieste, Italy.

Fiona Ecarnot (F)

Department of Thoracic and Cardiovascular Surgery, University Hospital Jean-Minjoz, Besançon, France.

Rossana Bussani (R)

Department of Pathological Anatomy, Trieste University Hospital, Trieste, Italy.

Aniello Pappalardo (A)

Cardio-Thoracic and Vascular Department, Trieste University Hospital, Trieste, Italy.

Sidney Chocron (S)

Department of Thoracic and Cardiovascular Surgery, University Hospital Jean-Minjoz, Besançon, France.

Thierry Folliguet (T)

Department of Cardio-Thoracic Surgery, University Hospital Henri-Mondor, Créteil, Paris, France.

Andrea Perrotti (A)

Department of Thoracic and Cardiovascular Surgery, University Hospital Jean-Minjoz, Besançon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH